Sat 28 Nov 2009 | 10:03 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For StemCells Inc

StemCells Inc (STEM.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View STEM on other exchanges

As of 27 Nov 2009

1.07USD

Price Change

-0.02

Percent Change

-1.83%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Craig, Stewart	47	2008	Senior Vice President - Development and Operations
McGlynn, Martin	62	2001	President, Chief Executive Officer, Director
Stratton, Kenneth	40	2007	General Counsel
Tsukamoto, Ann	56	2008	Executive Vice President - Research and Development
Weissman, Irving	69	1997	Director
Perlmutter, Roger	56	2000	Director
Levy, Ricardo	64	2001	Director
Bjerkholt, Eric	49	2004	Director
Young, Rodney	46	2006	Chief Financial Officer, Vice President - Finance and Administration
Schwartz, John	74	1998	Chairman of the Board

Find out more about STEM.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.